BioRestorative Therapies (BRTX) Long-Term Debt Issuances (2010 - 2020)

BioRestorative Therapies (BRTX) has 11 years of Long-Term Debt Issuances data on file, last reported at $3.8 million in Q4 2020.

• Quarterly Long-Term Debt Issuances rose 50.59% year-over-year to $3.8 million in Q4 2020, while the trailing twelve-month figure through Dec 2021 was $3.8 million (down 10.3% YoY) and the FY2021 annual result came in at $250000.0, down 94.17% from the prior year.
• Long-Term Debt Issuances rose to $3.8 million in Q4 2020, from $441762.0 in the prior quarter.
• In the past five years, Long-Term Debt Issuances ranged from a high of $6.1 million in Q3 2019 to a low of -$3.0 million in Q4 2018.
• A 5-year average of $1.1 million and a median of $499500.0 in 2016 frame the typical range for Long-Term Debt Issuances.
• The widest YoY moves for Long-Term Debt Issuances: up 201914.47% in 2018, down 9812.5% in 2018.
• Tracing BRTX's Long-Term Debt Issuances over 5 years: stood at $499000.0 in 2016, then jumped by 399.34% to $2.5 million in 2017, then plunged by 221.35% to -$3.0 million in 2018, then surged by 184.52% to $2.6 million in 2019, then surged by 50.59% to $3.8 million in 2020.
• The last three Long-Term Debt Issuances figures came in at $3.8 million (Q4 2020), $441762.0 (Q1 2020), and $2.6 million (Q4 2019), per Business Quant data.